AI Focus At NHSX Lets Clinicians 'Function At The Top Of Their License'

Less than 2% of NHS England’s budget is spent on digital technology, compared with 4-5% in other industries, NHS chief information officer Dr. Simon Eccles told delegates at the NHS Health and Care Innovation Expo 2019 this week. But the new NHS AI Lab is seen as a big step in the right direction.

Artifical_Intelligence_Brain

NHS chief executive Simon Stevens was rushing through the list of new NHS England achievements small and large as he addressed the huge crowds in two separate arenas at the NHS Expo 2019. He listed, for example, the Christie NHS Foundation Trust’s treatment of 80 patients in its proton beam therapy unit since it began receiving patients in December 2018. It is the first of two PBT centers being set up by NHS England.

He also pointed to NICE’s recommendation that the NHS use Novartis’ Luxturna gene therapy in children with vision loss caused...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

Aneira Health Launches New Precision Medicine Platform Exclusively For Women

 

Cecilia Lindgren, Aneira Health’s co-founder and chief science officer, said that the company has “redesigned the diagnostic model.” The subscription-based platform offers clinical-grade and AI diagnostics alongside clinical consultation.

UK Take Care! Regulatory And Market Access Reforms Must Not Shut Out Medtech Growth

 
• By 

Speakers at a recent UK medtech outlook conference voiced optimism about the sector’s prospects, but warned that cost burdens, over-regulation and lengthy processes will impede the capacity of local SMEs to innovate. Only 10% of NHS procured medtech comes from UK manufacturers.

Roche Diagnostics Day 2025: ‘We Need To Become A Leader In Decentralized Testing’

 

Roche aims to grow its diagnostics sales by mid to high single digits, said CEO of Roche Diagnostics Matt Sause. The company unveiled the Axelios synthesis and sequencing solution and discussed its “long-term commitment” to China, as well as its business strategy for the next five years.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

More from Europe